JPM vs NKX
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
NKX presents a conflicted profile, characterized by a weak Piotroski F-Score of 3/9 and a bearish technical trend, which signals underlying fundamental fragility. However, as a municipal income fund, its primary value proposition is its 7.34% dividend yield and a sustainable payout ratio of 61.59%. While profitability metrics like ROE (-6.22%) and profit margins are deeply negative, the fund maintains a reasonable Price-to-Book ratio of 1.08. The asset is essentially an income vehicle trading near its net asset value, lacking growth catalysts but providing steady yield.
Compare Another Pair
Related Comparisons
JPM vs NKX: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Nuveen California AMT-Free Quality Municipal Income Fund (NKX) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.